CAS: 769905-89-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Everolimus Hydrolized Impurity REF: 4Z-E-1012CAS: | - - - | To inquire | Fri 13 Dec 24 |
 | seco Everolimus B (~90%) REF: TR-E945410CAS: 769905-89-7 | ~90% | 446.00 €~4,933.00 € | Mon 16 Dec 24 |
 | Seco everolimus B REF: 3D-UFB90589CAS: 769905-89-7 | Min. 95% | To inquire | Fri 17 Jan 25 |
Ref: 4Z-E-1012
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
seco Everolimus B (~90%)
Controlled ProductCAS:769905-89-7
Applications seco Everolimus B is a metabolite of Everolimus (E945400); an immunosuppressant macrolide and analog …
Formula:
C53H85NO15
Purity:
~90%
Color and Shape:
Neat
Molecular weight:
976.24
Ref: TR-E945410
| 1mg | 1,366.00 € | ||
| 5mg | 4,933.00 € | ||
| 250µg | 446.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Seco everolimus B
CAS:769905-89-7
Seco everolimus B is a drug product that has not been approved by the FDA. …
Formula:
C53H85NO15
Purity:
Min. 95%
Molecular weight:
976.24 g/mol
Ref: 3D-UFB90589
| 1mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
